Answer
Cemiplimab (Libtayo) is contraindicated in patients with hypersensitivity to cemiplimab or any excipient listed in section 6.1.
Sources for this answer
- LIBTAYO 350 mg concentrate for solution for infusion.Regeneron UK Limited · emc · SmPC §4.3 Contraindications · Version 25Document updated
Sources checked